LYC Healthcare Berhad (KLSE:LYC)
Malaysia · Delayed Price · Currency is MYR 0.0150
-0.0050 (-25.00%)
At close: Oct 2, 2025
LYC Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is April - March.
Millions MYR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 148.22 | 155.52 | 128.99 | 92.28 | 64.6 | 26.41 | Upgrade | |
Revenue Growth (YoY) | 4.57% | 20.57% | 39.78% | 42.86% | 144.56% | 112.43% | Upgrade |
Cost of Revenue | 83.66 | 86.55 | 60.72 | 50.7 | 32.41 | 14.79 | Upgrade |
Gross Profit | 64.56 | 68.97 | 68.27 | 41.58 | 32.19 | 11.62 | Upgrade |
Selling, General & Admin | 66.1 | 68.81 | 74.67 | 39.94 | 32.15 | 18.8 | Upgrade |
Other Operating Expenses | -4.7 | -4.17 | -6.01 | -0.15 | -7.63 | -1.79 | Upgrade |
Operating Expenses | 61.49 | 64.73 | 69.94 | 40.01 | 24.55 | 17.01 | Upgrade |
Operating Income | 3.07 | 4.24 | -1.67 | 1.57 | 7.64 | -5.39 | Upgrade |
Interest Expense | -11.24 | -10.71 | -9.47 | -11.22 | -8.76 | -3.96 | Upgrade |
Interest & Investment Income | 0.22 | 0.23 | 0.39 | 0.26 | 0.11 | 0.09 | Upgrade |
Earnings From Equity Investments | -0.12 | -0.19 | -1.4 | -2.23 | -0.51 | - | Upgrade |
Other Non Operating Income (Expenses) | -0.08 | -0.08 | -0.07 | -0.05 | -0.05 | -0.03 | Upgrade |
EBT Excluding Unusual Items | -8.14 | -6.5 | -12.22 | -11.67 | -1.58 | -9.29 | Upgrade |
Merger & Restructuring Charges | - | - | -0.07 | -0.19 | -0.29 | -0.21 | Upgrade |
Asset Writedown | -1.59 | -1.59 | -0.55 | - | - | -2.18 | Upgrade |
Other Unusual Items | - | - | - | - | 0.64 | 0.5 | Upgrade |
Pretax Income | -9.73 | -8.09 | -12.84 | -11.86 | -1.22 | -11.18 | Upgrade |
Income Tax Expense | 4.02 | 4.13 | 3.68 | 2.93 | 3.03 | 0.28 | Upgrade |
Earnings From Continuing Operations | -13.76 | -12.22 | -16.52 | -14.8 | -4.25 | -11.46 | Upgrade |
Net Income to Company | -13.76 | -12.22 | -16.52 | -14.8 | -4.25 | -11.46 | Upgrade |
Minority Interest in Earnings | -4.43 | -4.85 | -4.26 | -4.39 | -4.97 | -0.4 | Upgrade |
Net Income | -18.19 | -17.07 | -20.78 | -19.19 | -9.23 | -11.87 | Upgrade |
Net Income to Common | -18.19 | -17.07 | -20.78 | -19.19 | -9.23 | -11.87 | Upgrade |
Shares Outstanding (Basic) | 726 | 715 | 715 | 550 | 436 | 362 | Upgrade |
Shares Outstanding (Diluted) | 726 | 715 | 715 | 550 | 436 | 362 | Upgrade |
Shares Change (YoY) | 1.28% | - | 29.88% | 26.33% | 20.38% | 9.20% | Upgrade |
EPS (Basic) | -0.03 | -0.02 | -0.03 | -0.03 | -0.02 | -0.03 | Upgrade |
EPS (Diluted) | -0.03 | -0.02 | -0.03 | -0.03 | -0.02 | -0.03 | Upgrade |
Free Cash Flow | 40.93 | 23.06 | 5.03 | 2.46 | -2.54 | -5.58 | Upgrade |
Free Cash Flow Per Share | 0.06 | 0.03 | 0.01 | 0.00 | -0.01 | -0.01 | Upgrade |
Gross Margin | 43.56% | 44.35% | 52.92% | 45.06% | 49.83% | 44.00% | Upgrade |
Operating Margin | 2.07% | 2.73% | -1.29% | 1.70% | 11.83% | -20.39% | Upgrade |
Profit Margin | -12.27% | -10.97% | -16.11% | -20.79% | -14.28% | -44.92% | Upgrade |
Free Cash Flow Margin | 27.62% | 14.82% | 3.90% | 2.67% | -3.93% | -21.14% | Upgrade |
EBITDA | 13.41 | 12.37 | 5.92 | 4.84 | 10.4 | -3.24 | Upgrade |
EBITDA Margin | 9.05% | 7.95% | 4.59% | 5.24% | 16.10% | -12.28% | Upgrade |
D&A For EBITDA | 10.34 | 8.13 | 7.59 | 3.27 | 2.76 | 2.14 | Upgrade |
EBIT | 3.07 | 4.24 | -1.67 | 1.57 | 7.64 | -5.39 | Upgrade |
EBIT Margin | 2.07% | 2.73% | -1.29% | 1.70% | 11.83% | -20.39% | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.